CorMedix wins US approval via rarely-used pathway for drug to reduce bloodstream infections

Zachary Brennan

Senior Editor

The FDA on Wednesday approved CorMedix’s Defencath (taurolidine and heparin) to reduce catheter-related bloodstream infections in adults with kidney failure who are receiving chronic hemodialysis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CorMedix wins US approval via rarely-used pathway for drug to reduce bloodstream infections

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out

Major FDA staff cuts would slow drug reviews, experts say

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Bristol Myers prunes pipeline amid new round of cost cuts

Roche heads to FDA with Gazyva results in a form of lupus

CorMedix wins US ap­proval via rarely-used path­way for drug to re­duce blood­stream in­fec­tions

Zachary Brennan

Senior Editor

Sign up to read this article for free.

more like this

Up­dat­ed: Bay Area biotech VC to shut down 15 months af­ter launch, sources say, af­ter key in­vestor pulls out

Ma­jor FDA staff cuts would slow drug re­views, ex­perts say

Bain buys Mit­subishi Tan­abe Phar­ma in $3.3B bet on Japan

Sen­a­tors ask FDA to dig in­to 'mis­lead­ing' Su­per Bowl ad from Hims

Bris­tol My­ers prunes pipeline amid new round of cost cuts

Roche heads to FDA with Gazy­va re­sults in a form of lu­pus

CorMedix wins US approval via rarely-used pathway for drug to reduce bloodstream infections

Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out

Major FDA staff cuts would slow drug reviews, experts say

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Bristol Myers prunes pipeline amid new round of cost cuts

Roche heads to FDA with Gazyva results in a form of lupus